My understanding the P1 and P2 trials are fully funded using the oppies conversion next year as well as other oppies conversion (I think Dr T has a large amount this year) and also tax credits and the very diligent money management thanks to Dr T and also the board, so I am not really concerned. Only time we will need money is to go to P3 (hopefully we will get partnered up unless bought out which could be a real possibility after P2) or doing other currently not known trials. Dr T mentioned he could run several trials, just would need quite a bit of money and he does not want to dilute the shareholders to oblivion, so they are very selective what goes ahead and what's not. .
RAC Price at posting:
$1.25 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)